Registro:

Referencias:

• Balana, M.E., Labriola, L., Salatino, M., Movsichoff, F., Peters, G., Charreau, E.H., Elizalde, P.V., Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells (2001) Oncogene, 20, pp. 34-47
• Balana, M.E., Lupu, R., Labriola, L., Charreau, E.H., Elizalde, P.V., Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas (1999) Oncogene, 18, pp. 6370-6379
• Boonyaratanakornkit, V., Bi, Y., Rudd, M., Edwards, D.P., The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression (2008) Steroids, 73, pp. 922-928
• Boonyaratanakornkit, V., McGowan, E., Sherman, L., Mancini, M.A., Cheskis, B.J., Edwards, D.P., The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle (2007) Mol. Endocrinol, 21, pp. 359-375
• Boonyaratanakornkit, V., Scott, M.P., Ribon, V., Sherman, L., Anderson, S.M., Maller, J.L., Miller, W.T., Edwards, D.P., Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases (2001) Mol. Cell, 8, pp. 269-280
• Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:2553-2558; Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat3 as an oncogene. Cell 98:295-303; Burke, W.M., Jin, X., Lin, H.J., Huang, M., Liu, R., Reynolds, R.K., Lin, J., Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells (2001) Oncogene, 20, pp. 7925-7934
• Daniel, A.R., Qiu, M., Faivre, E.J., Ostrander, J.H., Skildum, A., Lange, C.A., Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth (2007) Steroids, 72, pp. 188-201
• Dankort, D., Jeyabalan, N., Jones, N., Dumont, D.J., Muller, W.J., Multiple ErbB-2/Neu phosphorylation sites mediate transformation through distinct effector proteins (2001) J. Biol. Chem, 276, pp. 38921-38928
• Dankort, D., B. Maslikowski, N. Warner, N. Kanno, H. Kim, Z. Wang, M. F. Moran, R. G. Oshima, R. D. Cardiff, and W. J. Muller. 2001. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol. Cell. Biol. 21:1540-1551; Diaz, N., Minton, S., Cox, C., Bowman, T., Gritsko, T., Garcia, R., Eweis, I., Muro-Cacho, C.A., Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression (2006) Clin. Cancer Res, 12, pp. 20-28
• Dran, G., Luthy, I.A., Molinolo, A.A., Montecchia, F., Charreau, E.H., Pasqualini, C.D., Lanari, C., Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma (1995) Breast Cancer Res. Treat, 35, pp. 173-186
• Faivre, E.J., Daniel, A.R., Hillard, C.J., Lange, C.A., Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors (2008) Mol. Endocrinol, 22, pp. 823-837
• Garcia, R., Bowman, T.L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C.A., Cox, C.E., Jove, R., Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells (2001) Oncogene, 20, pp. 2499-2513
• Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Jove, R., Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells (2006) Clin. Cancer Res, 12, pp. 11-19
• Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W.J., Inghirami, G., Giancotti, F.G., Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis (2006) Cell, 126, pp. 489-502
• Ishizawar, R.C., Miyake, T., Parsons, S.J., c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function (2007) Oncogene, 26, pp. 3503-3510
• Kim, H., Chan, R., Dankort, D.L., Zuo, D., Najoukas, M., Park, M., Muller, W.J., The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: Implications for ErbB-2 mediated signaling and transformation (2005) Oncogene, 24, pp. 7599-7607
• Labriola, L., Salatino, M., Proietti, C.J., Pecci, A., Coso, O.A., Kornblihtt, A.R., Charreau, E.H., Elizalde, P.V., Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells (2003) Mol. Cell. Biol, 23, pp. 1095-1111
• Lange, C.A., Richer, J.K., Shen, T., Horwitz, K.B., Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways (1998) J. Biol. Chem, 273, pp. 31308-31316
• Lange, C.A., Shen, T., Horwitz, K.B., Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 1032-1037
• Li, L., Shaw, P.E., Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines (2002) J. Biol. Chem, 277, pp. 17397-17405
• Lupu, R., Dickson, R.B., Lippman, M.E., The role of erbB-2 and its ligands in growth control of malignant breast epithelium (1992) J. Steroid Biochem. Mol. Biol, 43, pp. 229-236
• Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Auricchio, F., Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor (1998) EMBO J, 17, pp. 2008-2018
• Olayioye, M.A., Beuvink, I., Horsch, K., Daly, J.M., Hynes, N.E., ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases (1999) J. Biol. Chem, 274, pp. 17209-17218
• Olayioye, M.A., Neve, R.M., Lane, H.A., Hynes, N.E., The ErbB signaling network: Receptor heterodimerization in development and cancer (2000) EMBO J, 19, pp. 3159-3167
• Proietti, C., Salatino, M., Rosemblit, C., Carnevale, R., Pecci, A., Kornblihtt, A.R., Molinolo, A.A., Elizalde, P.V., Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells (2005) Mol. Cell. Biol, 25, pp. 4826-4840
• Real, P.J., Sierra, A., De Juan, A., Segovia, J.C., Lopez-Vega, J.M., Fernandez-Luna, J.L., Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells (2002) Oncogene, 21, pp. 7611-7618
• Ren, Z., Schaefer, T.S., ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner (2002) J. Biol. Chem, 277, pp. 38486-38493
• Sam, M.R., Elliott, B.E., Mueller, C.R., A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells (2007) Mol. Cancer, 6, p. 69
• Shen, T., Horwitz, K.B., Lange, C.A., Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent downregulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294 (2001) Mol. Cell. Biol, 21, pp. 6122-6131
• Simian, M., Molinolo, A., Lanari, C., Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression (2006) Am. J. Pathol, 168, pp. 270-279
• Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Ullrich, A., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer (1989) Science, 244, pp. 707-712
• Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J., Yarden, Y., A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor (1996) Mol. Cell. Biol, 16, pp. 5276-5287
• Wang, S.C., Lien, H.C., Xia, W., Chen, I.F., Lo, H.W., Wang, Z., Ali-Seyed, M., Hung, M.C., Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 (2004) Cancer Cell, 6, pp. 251-261
• Xu, W., Yuan, X., Beebe, K., Xiang, Z., Neckers, L., Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity (2007) Mol. Cell. Biol, 27, pp. 220-228
• Yu, H., Jove, R., The STATs of cancer - new molecular targets come of age (2004) Nat. Rev. Cancer, 4, pp. 97-105
• Zhang, Y., Bai, W., Allgood, V.E., Weigel, N.L., Multiple signaling pathways activate the chicken progesterone receptor (1994) Mol. Endocrinol, 8, pp. 577-584

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------